Biocept Inc. (BIOCQ)

Biocept Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018
Cash & Equivalents	12.9	28.86	14.37	9.3	3.42
Cash & Cash Equivalents	12.9	28.86	14.37	9.3	3.42
Cash Growth	-55.32%	100.89%	54.47%	171.70%	59.48%
Receivables	2.15	13.79	14.15	3.53	1.57
Inventory	0.76	2.65	1.93	0.77	0.59
Other Current Assets	0.54	0.39	2.15	0.3	0.43
Total Current Assets	16.34	45.69	32.6	13.89	6.01
Property, Plant & Equipment	14.14	14.27	14.43	3.84	2.74
Other Long-Term Assets	0.39	0.46	0.43	0	0
Total Long-Term Assets	14.53	14.73	14.86	3.84	2.74
Total Assets	30.87	60.42	47.45	17.73	8.75
Accounts Payable	1.52	7.25	8.37	2.01	2.04
Current Debt	1.73	1.51	0.96	1.57	0.64
Other Current Liabilities	2.25	3.02	3.17	1.98	1.93
Total Current Liabilities	5.51	11.77	12.5	5.56	4.61
Long-Term Debt	10.38	11.16	11.27	0.97	0.99
Other Long-Term Liabilities	6.13	0	0	0	0.11
Total Long-Term Liabilities	16.51	11.16	11.27	0.97	1.1
Total Liabilities	22.01	22.94	23.76	6.53	5.71
Total Debt	12.11	12.67	12.23	2.54	1.63
Debt Growth	-4.45%	3.63%	381.46%	56.16%	-41.68%
Retained Earnings	-298.44	-266.35	-263.53	-245.72	-220.46
Shareholders' Equity	8.86	37.48	23.69	11.2	3.04
Net Cash / Debt	0.79	16.19	2.14	6.76	1.8
Net Cash / Debt Growth	-95.13%	656.94%	-68.36%	276.30%	-
Net Cash Per Share	1.39	32.87	5.42	98.18	192.65
Working Capital	10.84	33.92	20.1	8.33	1.4
Book Value Per Share	15.68	76.10	60.00	162.64	326.19

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).